AEMD Stock Analysis: Buy, Sell, or Hold?
AEMD - AETHLON MEDICAL INC
$2.83
-0.10 (-3.41%)
▼
5d:
-10.16%
30d:
+322.33%
90d:
+32.24%
WAIT
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When AEMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: AEMD is down 10.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: AEMD is down 10.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: AEMD is currently trading at $2.83, which is considered extended relative to its 30-day fair value range of $0.25 to $2.56.
Technical Outlook: Technically, AEMD is in a downtrend. Immediate support is located at $0.63, while resistance sits at $3.75. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: AEMD scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $16.25 (+474.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AEMD is in a downtrend. Immediate support is located at $0.63, while resistance sits at $3.75. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: AEMD scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $16.25 (+474.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.25 -
$2.56
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
10.5%
All Signals
- BEARISH: Price significantly overextended (+10.5% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 474.2% below Wall St target ($16.25)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.25 -
$2.56
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.63
Resistance Level
$3.75
Current Trend
Downtrend
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.89
Wall Street Target
$16.25
(+474.2%)
Revenue Growth (YoY)
4278.2%
Share & Embed Analysis
Last updated: August 15, 2026 2:19 AM ET
Data refreshes hourly during market hours. Next update: 3:19 AM
Data refreshes hourly during market hours. Next update: 3:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AEMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$382 | 48 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 28 SELL |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 41 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 29 SELL |
